Works matching IS 03618609 AND DT 2018 AND VI 93 AND IP 11

Results: 31
    1
    2
    3

    Outcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1394, doi. 10.1002/ajh.25261
    By:
    • Mato, Anthony R.;
    • Roeker, Lindsey E.;
    • Allan, John N.;
    • Pagel, John M.;
    • Brander, Danielle M.;
    • Hill, Brian T.;
    • Cheson, Bruce D.;
    • Furman, Richard R.;
    • Lamanna, Nicole;
    • Tam, Constantine S.;
    • Handunnetti, Sasanka;
    • Jacobs, Ryan;
    • Lansigan, Frederick;
    • Bhavsar, Erica;
    • Barr, Paul M.;
    • Shadman, Mazyar;
    • Skarbnik, Alan P.;
    • Goy, Andre;
    • Beach, Douglas F.;
    • Svoboda, Jakub
    Publication type:
    Article
    4

    Prognostic factors of disease severity in infants with sickle cell anemia: A comprehensive longitudinal cohort study.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1411, doi. 10.1002/ajh.25260
    By:
    • Brousse, Valentine;
    • El Hoss, Sara;
    • Bouazza, Naïm;
    • Arnaud, Cécile;
    • Bernaudin, Francoise;
    • Pellegrino, Béatrice;
    • Guitton, Corinne;
    • Odièvre‐Montanié, Marie‐Hélène;
    • Mames, David;
    • Brouzes, Chantal;
    • Picard, Véronique;
    • Nguyen‐Khoa, Thao;
    • Pereira, Catia;
    • Lapouméroulie, Claudine;
    • Pissard, Serge;
    • Gardner, Kate;
    • Menzel, Stephan;
    • Le Van Kim, Caroline;
    • Colin‐Aronovicz, Yves;
    • Buffet, Pierre
    Publication type:
    Article
    5

    Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1402, doi. 10.1002/ajh.25259
    By:
    • Robak, Tadeusz;
    • Burger, Jan A.;
    • Tedeschi, Alessandra;
    • Barr, Paul M.;
    • Owen, Carolyn;
    • Bairey, Osnat;
    • Hillmen, Peter;
    • Simpson, David;
    • Grosicki, Sebastian;
    • Devereux, Stephen;
    • McCarthy, Helen;
    • Coutre, Steven E.;
    • Quach, Hang;
    • Gaidano, Gianluca;
    • Maslyak, Zvenyslava;
    • Stevens, Don A.;
    • Moreno, Carol;
    • Gill, Devinder S.;
    • Flinn, Ian W.;
    • Gribben, John G.
    Publication type:
    Article
    6
    7

    Optimal conditioning regimen for haplo‐identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de‐escalation study of TBI and ATG dose.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1368, doi. 10.1002/ajh.25257
    By:
    • Lee, Sung‐Eun;
    • Park, Sung Soo;
    • Jeon, Young‐Woo;
    • Yoon, Jae‐Ho;
    • Cho, Byung‐Sik;
    • Eom, Ki‐Seong;
    • Kim, Yoo‐Jin;
    • Lee, Seok;
    • Min, Chang‐Ki;
    • Kim, Hee‐Je;
    • Cho, Seok‐Goo;
    • Kim, Dong‐Wook;
    • Lee, Jong Wook
    Publication type:
    Article
    8

    Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T‐ALL like mutations.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1358, doi. 10.1002/ajh.25256
    By:
    • Mi, Xiaoli;
    • Griffin, Gabriel;
    • Lee, Winston;
    • Patel, Sanjay;
    • Ohgami, Robert;
    • Ok, Chi Young;
    • Wang, Sa;
    • Geyer, Julia T.;
    • Xiao, Wenbin;
    • Roshal, Mikhail;
    • Garcia, Jacqueline S.;
    • Silverman, Lewis B.;
    • Sallan, Stephen E.;
    • Aster, Jon C.;
    • Harris, Marian H.;
    • Weinberg, Olga K.
    Publication type:
    Article
    9

    P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse‐free survival.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1376, doi. 10.1002/ajh.25255
    By:
    • Assi, Rita;
    • Gur, Hatice D.;
    • Loghavi, Sanam;
    • Konoplev, Sergej N.;
    • Konopleva, Marina;
    • Daver, Naval;
    • Tashakori, Mehrnoosh;
    • Kadia, Tapan;
    • Routbort, Mark;
    • Salem, Alireza;
    • Kanagal‐Shamanna, Rashmi;
    • Quesada, Andres;
    • Jabbour, Elias J.;
    • Kornblau, Steven M.;
    • Medeiros, L. Jeffrey;
    • Kantarjian, Hagop;
    • Khoury, Joseph D.
    Publication type:
    Article
    10

    Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1384, doi. 10.1002/ajh.25254
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Winters, Jeffrey;
    • Gertz, Morie A.;
    • King, Rebecca L.;
    • Murray, David;
    • Habermann, Thomas;
    • Dingli, David;
    • Muchtar, Eli;
    • Go, Ronald S.;
    • Leung, Nelson;
    • Inwards, David J;
    • Buadi, Francis K.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Lin, Yi;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Witzig, Thomas E.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    A multimodality work‐up of patients with Hypereosinophilia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1337, doi. 10.1002/ajh.25247
    By:
    • Hu, Zhihong;
    • Boddu, Prajwal C.;
    • Loghavi, Sanam;
    • Miranda, Roberto N.;
    • Goswami, Maitrayee;
    • Jeffrey, Medeiros L;
    • Tam, Wayne;
    • Orazi, Attilio;
    • Verstovsek, Srdan;
    • Wang, Sa A.
    Publication type:
    Article
    17
    18
    19
    20

    Duvelisib, an oral dual PI3K‐δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1318, doi. 10.1002/ajh.25243
    By:
    • O'Brien, Susan;
    • Patel, Manish;
    • Kahl, Brad S.;
    • Horwitz, Steven M.;
    • Foss, Francine M.;
    • Porcu, Pierluigi;
    • Jones, Jeffrey;
    • Burger, Jan;
    • Jain, Nitin;
    • Allen, Kerstin;
    • Faia, Kerrie;
    • Douglas, Mark;
    • Stern, Howard M.;
    • Sweeney, Jennifer;
    • Kelly, Patrick;
    • Kelly, Virginia;
    • Flinn, Ian
    Publication type:
    Article
    21
    22

    Prognostic significance of hyperdiploidy in adult acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. E357, doi. 10.1002/ajh.25240
    By:
    • Abaza, Yasmin;
    • Cortes, Jorge;
    • Ravandi, Farhad;
    • Kadia, Tapan;
    • Garcia‐Manero, Guillermo;
    • Pemmaraju, Naveen;
    • Shetty, Aditya;
    • Pierce, Sherry;
    • Qiao, Wei;
    • Kantarjian, Hagop M.;
    • Borthakur, Gautam
    Publication type:
    Article
    23
    24

    Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1301, doi. 10.1002/ajh.25238
    By:
    • Cortes, Jorge E.;
    • Douglas Smith, B.;
    • Wang, Eunice S.;
    • Merchant, Akil;
    • Oehler, Vivian G.;
    • Arellano, Martha;
    • DeAngelo, Daniel J.;
    • Pollyea, Daniel A.;
    • Sekeres, Mikkael A.;
    • Robak, Tadeusz;
    • Ma, Weidong Wendy;
    • Zeremski, Mirjana;
    • Naveed Shaik, M.;
    • Douglas Laird, A.;
    • O'Connell, Ashleigh;
    • Chan, Geoffrey;
    • Schroeder, Mark A.
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31